Piety Rocha is the Director, Head of Regulatory Affairs & Country VDC Head at Pharmalex, Australia. She has more than 20 years of experience in the Australian and New Zealand pharmaceutical industry. Piety is a seasoned regulatory affairs professional with a proven track record of delivering successful outcomes for complex and challenging projects. Piety has extensive knowledge and expertise covering innovative and generic prescription medicines across multiple therapeutic areas. Piety’s strengths lie in leading and managing a team of regulatory affairs specialists and providing strategic guidance and support to a diverse portfolio of clients, including generics manufacturers, innovators, and biosimilars developers. Piety is passionate about delivering regulatory excellence and ensuring patient access to safe and effective medicines.

Andrew has been with the Department of Health since 2015. Andrew has an extensive background in health policy. Prior to joining the PMAB team, he worked on the Primary Care Reform Taskforce and before that worked on the Department’s COVID-19 primary care response with responsibility for introducing telehealth Medicare items. He has also led the Medicare Review Taskforce.